July 7, 2021 — Amid the COVID-19 crisis, the global market for single photon emission computed tomography (SPECT) estimated at $1.7 billion in the year 2020, is projected to reach a revised size of $2.7 billion by 2027, growing at a CAGR of 6.8% over the period 2020-2027.
Standalone, one of the segments analyzed in the report, is projected to grow at a 6.2% CAGR to reach $1.4 billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the hybrid segment is readjusted to a revised 7.5% CAGR for the next 7-year period. This segment currently accounts for a 43.8% share of the global SPECT market.
U.S. Accounts for Over 36.1% of Global Market Size in 2020
The SPECT market in the U.S. is estimated at US$608.4 Million in the year 2020. The country currently accounts for a 36.07% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of $298.9 Million in the year 2027 trailing a CAGR of 9.4% through 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.5% and 6.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR while Rest of European market (as defined in the study) will reach $298.9 Million by the year 2027.
For more information on this report: researchandmarkets.com
April 17, 2024 
